|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
1,290,000,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0 - $0 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Vaxcyte is a clinical-stage vaccine company. Co. is developing conjugate and protein vaccines to treat bacterial infectious diseases. Co.'s primary vaccine candidate, VAX-24, is a 24-valent investigational pneumococcal conjugate vaccine (PCV) for the treatment of invasive pneumococcal disease and pneumonia. Co.'s second PCV candidate, VAX-XP, is designed to expand the breadth of coverage to greater than 30 strains without compromising immunogenicity due to carrier suppression. In addition, Co.'s pipeline includes VAX-A1, a conjugate vaccine candidate designed to treat Group A Strep and VAX-PG, a protein vaccine candidate targeting the keystone pathogen responsible for periodontitis.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
21,366 |
21,366 |
42,366 |
582,439 |
| Total Sell Value |
$1,011,863 |
$1,011,863 |
$2,622,550 |
$51,344,006 |
| Total People Sold |
2 |
2 |
5 |
8 |
| Total Sell Transactions |
2 |
2 |
5 |
69 |
| End Date |
2025-11-09 |
2025-08-08 |
2025-02-07 |
2024-02-08 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Brandicourt Olivier |
Director |
– • – |
2026-01-15 |
4 |
A |
$0.00 |
$0 |
D/D |
1,357 |
2,505 |
|
- |
|
| Guggenhime Andrew |
PRESIDENT AND CFO |
• – – |
2026-01-14 |
4 |
GA |
$0.00 |
$0 |
I/I |
61,850 |
61,850 |
|
- |
|
| Guggenhime Andrew |
PRESIDENT AND CFO |
• – – |
2026-01-14 |
4 |
GD |
$0.00 |
$0 |
D/D |
61,850 |
62,459 |
|
- |
|
| Pickering Grant |
CHIEF EXECUTIVE OFFICER |
• • – |
2026-01-14 |
4 |
GD |
$0.00 |
$0 |
D/D |
100,000 |
400,908 |
|
- |
|
| Dhaliwal Harpreet S. |
Chief Technical Ops Officer |
• – – |
2025-12-31 |
4 |
S |
$46.69 |
$454,891 |
D/D |
(9,743) |
23,928 |
|
- |
|
| Cowan Elvia |
SVP, FINANCE |
• – – |
2025-12-23 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,000 |
13,534 |
|
- |
|
| Cowan Elvia |
SVP, FINANCE |
• – – |
2025-12-23 |
4 |
S |
$47.90 |
$556,972 |
D/D |
(11,623) |
14,534 |
|
- |
|
| Pickering Grant |
CHIEF EXECUTIVE OFFICER |
• • – |
2025-09-08 |
4 |
D |
$32.41 |
$238,408 |
D/D |
(7,356) |
500,908 |
|
- |
|
| Cowan Elvia |
SVP, FINANCE |
• – – |
2025-09-08 |
4 |
D |
$32.41 |
$15,622 |
D/D |
(482) |
26,156 |
|
- |
|
| Dhaliwal Harpreet S. |
Chief Technical Ops Officer |
• – – |
2025-09-08 |
4 |
D |
$32.41 |
$39,022 |
D/D |
(1,204) |
33,670 |
|
- |
|
| Guggenhime Andrew |
PRESIDENT AND CFO |
• – – |
2025-09-08 |
4 |
D |
$32.41 |
$93,665 |
D/D |
(2,890) |
124,309 |
|
- |
|
| Wassil Jim |
CHIEF OPERATING OFFICER |
• – – |
2025-09-08 |
4 |
D |
$32.41 |
$89,419 |
D/D |
(2,759) |
141,848 |
|
- |
|
| Cowan Elvia |
SVP, FINANCE |
• – – |
2025-09-07 |
4 |
A |
$0.00 |
$0 |
D/D |
2,810 |
27,205 |
|
- |
|
| Wassil Jim |
CHIEF OPERATING OFFICER |
• – – |
2025-09-02 |
4 |
D |
$31.56 |
$135,266 |
D/D |
(4,286) |
146,270 |
|
- |
|
| Guggenhime Andrew |
PRESIDENT AND CFO |
• – – |
2025-09-02 |
4 |
D |
$31.56 |
$160,325 |
D/D |
(5,080) |
127,199 |
|
- |
|
| Cowan Elvia |
SVP, FINANCE |
• – – |
2025-09-02 |
4 |
D |
$31.56 |
$17,895 |
D/D |
(567) |
26,638 |
|
- |
|
| Pickering Grant |
CHIEF EXECUTIVE OFFICER |
• • – |
2025-09-02 |
4 |
D |
$31.56 |
$342,110 |
D/D |
(10,840) |
508,264 |
|
- |
|
| Dhaliwal Harpreet S. |
Chief Technical Ops Officer |
• – – |
2025-09-02 |
4 |
D |
$31.56 |
$48,539 |
D/D |
(1,538) |
34,874 |
|
- |
|
| Lukatch Heath |
Director |
– • – |
2025-06-12 |
4 |
A |
$0.00 |
$0 |
D/D |
3,041 |
17,216 |
|
- |
|
| Loxam Teri |
Director |
– • – |
2025-06-12 |
4 |
A |
$0.00 |
$0 |
D/D |
3,041 |
10,216 |
|
- |
|
| Paya Carlos V |
Director |
– • – |
2025-06-12 |
4 |
A |
$0.00 |
$0 |
D/D |
3,041 |
4,591 |
|
- |
|
| Gilbert Halley E |
Director |
– • – |
2025-06-12 |
4 |
A |
$0.00 |
$0 |
D/D |
3,041 |
10,216 |
|
- |
|
| Drapeau Anne S |
Director |
– • – |
2025-06-12 |
4 |
A |
$0.00 |
$0 |
D/D |
3,041 |
10,216 |
|
- |
|
| Lee Jacks |
Director |
– • – |
2025-06-12 |
4 |
A |
$0.00 |
$0 |
D/D |
3,041 |
4,591 |
|
- |
|
| Brandicourt Olivier |
Director |
– • – |
2025-06-12 |
4 |
A |
$0.00 |
$0 |
D/D |
1,148 |
1,148 |
|
- |
|
511 Records found
|
|
Page 1 of 21 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
